Any current/future new fundraising through debt or equity?

Mitsu Chem Plast is planning further fundraising but has not specified the exact method yet. The company is working on raising funds which may be done through various methods, including possibly a Qualified Institutional Placement (QIP). They have not finalized or announced the details but mentioned that an update will be provided soon. Current plans include continuing to reduce debt with existing resources. Any new funds raised will be utilized for growth purposes. The company is open to new fund raising methods but no definite timeline or amount was disclosed during the call.

Any current/future capex/capital investment/strategic investment?

The company plans to expand capacity in the next two years to support further growth. Currently, the plant is producing at about 64% capacity out of a maximum feasible 85%. To grow beyond this utilization, some form of capital expenditure (capex) will be required. The company has some in-house capacity that can be optimized to move from 64% to around 85% production before new capex is needed. Fundraising through QIP or other methods is being considered and may be announced soon to support growth plans. Debt reduction will continue with current levels, and any new funds raised will be used prim

Future growth expectations in sales/revenue/volumes?

The company expects robust growth especially in the hospital furniture and packaging segments. Hospital furniture segment grew by almost 50% in FY2021 and is expected to continue growing at a similar high rate for at least the next 3-4 years, supported by government medical infrastructure plans. Packaging segment showed growth around 42-43% and is expected to sustain growth due to chemical and pharmaceutical industry expansion. Overall volume growth for FY2022 was 28%. The company aims to increase capacity utilization from current 64% towards 85% through optimization, possibly requiring capex

Future growth expectations in earnings/operating earnings/profits/EPS?

Mitsu Chem Plast expects robust growth driven by hospital furniture and packaging segments, with furniture having grown ~50% recently and expected to sustain strong growth for 3-4 years. The company anticipates continued operational improvements and capacity optimization to support growth. Margins are targeted to be maintained or improved despite raw material cost volatility; 80-90% of cost inflation can be passed on to customers. Debt reduction efforts will continue, supporting bottom-line growth. Revenue milestone crossed Rs.258.9 Crores with 44% growth in FY2022; net profit grew 19%. Future

Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention the current or expected order book or pending orders for Mitsu Chem Plast Limited. However, the company has indicated strong demand growth across segments, especially in hospital furniture and packaging. The management highlighted adding 15+ new customers in the last quarter, reflecting growing order inflow. Indirect export orders improved in Q4 compared to earlier quarters, despite prior challenges due to freight costs. They are optimistic about continued growth in hospital furniture due to government healthcare infrastructure initiatives. Capacity u

Mitsu Chem Plast LtdQ4 FY22Industrial Products

Mitsu Chem Plast Ltd Q4 FY22 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹178P/E: 10.5Market Cap: ₹243 CrSector: Industrial Products

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2

The company expects robust growth especially in the hospital furniture and packaging segments.
Hospital furniture segment grew by almost 50% in FY2021 and is expected to continue growing at a similar high rate for at least the next 3-4 years, supported by government medical infrastructure plans.
Packaging segment showed growth around 42-43% and is expected to sustain growth due to chemical and pharmaceutical industry expansion.
Overall volume growth for FY2022 was 28%.
The company aims to increase capacity utilization from current 64% towards 85% through optimization, possibly requiring capex in the next two years.
Demand is expected to remain strong, driven by healthcare sector expansion and packaging needs.
Crude oil price volatility remains a challenge but long-term growth outlook remains positive.

Margin guidance

Category 3

Mitsu Chem Plast expects robust growth driven by hospital furniture and packaging segments, with furniture having grown ~50% recently and expected to sustain strong growth for 3-4 years.
The company anticipates continued operational improvements and capacity optimization to support growth.
Margins are targeted to be maintained or improved despite raw material cost volatility; 80-90% of cost inflation can be passed on to customers.
Debt reduction efforts will continue, supporting bottom-line growth.
Revenue milestone crossed Rs.258.9 Crores with 44% growth in FY2022; net profit grew 19%.
Future earnings growth may face margin pressure due to volatile crude oil prices but is expected to sustain positive trajectory.
Customized product offerings and client additions also support earnings growth.
Overall outlook is positive with continued focus on product innovation, cost control, and demand in key segments like hospital furniture bolstered by government initiatives.

See what Mitsu Chem Plast Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

Mitsu Chem Plast is planning further fundraising but has not specified the exact method yet.
The company is working on raising funds which may be done through various methods, including possibly a Qualified Institutional Placement (QIP).
They have not finalized or announced the details but mentioned that an update will be provided soon.
Current plans include continuing to reduce debt with existing resources.
Any new funds raised will be utilized for growth purposes.
The company is open to new fund raising methods but no definite timeline or amount was disclosed during the call.

Order book

The transcript does not explicitly mention the current or expected order book or pending orders for Mitsu Chem Plast Limited.
However, the company has indicated strong demand growth across segments, especially in hospital furniture and packaging.
The management highlighted adding 15+ new customers in the last quarter, reflecting growing order inflow.
Indirect export orders improved in Q4 compared to earlier quarters, despite prior challenges due to freight costs.
They are optimistic about continued growth in hospital furniture due to government healthcare infrastructure initiatives.
Capacity utilization is at 64%, with scope to increase to 85% without immediate capex, supporting the ability to handle increased orders.
The company plans to announce fund raising soon, likely to support further capacity expansion and order fulfillment.
Overall, Mitsu Chem Plast remains poised for robust order intake and operational momentum going forward.

See what Mitsu Chem Plast Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

The company plans to expand capacity in the next two years to support further growth.
Currently, the plant is producing at about 64% capacity out of a maximum feasible 85%.
To grow beyond this utilization, some form of capital expenditure (capex) will be required.
The company has some in-house capacity that can be optimized to move from 64% to around 85% production before new capex is needed.
Fundraising through QIP or other methods is being considered and may be announced soon to support growth plans.
Debt reduction will continue with current levels, and any new funds raised will be used primarily for growth and expansion.
No specific timeline or project details were disclosed at the time of the call; updates will be provided once plans are finalized.

Track Mitsu Chem Plast Ltd — get its next earnings analysis in your feed

How does Mitsu Chem Plast Ltd rank vs peers in Industrial Products?

Pro feature

ThisMitsu Chem Plast Ltd

Rev 2Mar 3

See where Mitsu Chem Plast Ltd sits in Industrial ProductsSee which companies these are, and every other name in the sector.Open rankings

How does Mitsu Chem Plast Ltd rank in Industrial Products?

Compare Mitsu Chem Plast Ltd against every Industrial Products company (Q4 FY22) on revenue, margins and earnings-call signals.

View Industrial Products leaderboard →

What Mitsu Chem Plast Ltd's management said in earlier quarters

Others in Industrial Products this season

Monolithisch India Ltd (Q2 FY27)
Combined additional capacity: 3 lakh MT per annum; total capex approximately INR 45 crores. Key concall takeaways from Monolithisch India Ltd's Q2 FY27…
Systematic Industries Ltd (Q1 FY27)
Year-on-Year (YoY) Growth for Q4 Net Sales:** 6.0% . Key concall takeaways from Systematic Industries Ltd's Q1 FY27 earnings call — and how it ranks against…
Graphite India Ltd (Q3 FY24)
690 crore, down 1.6% y-o-y (Page 5, 9) . Key concall takeaways from Graphite India Ltd's Q3 FY24 earnings call — and how it ranks against sector peers.
Graphite India Ltd (Q4 FY24)
720 Cr, down 11.7% y-o-y (Page 4, 9) . Key concall takeaways from Graphite India Ltd's Q4 FY24 earnings call — and how it ranks against sector peers.

Compare:vs Polycab India Ltd vs Welspun Corp Ltd vs APL Apollo Tubes

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →